Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Benitec Biopharma Inc. (BNTC)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 6, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Benitec Biopharma Inc. that it will not review their registration statement filed on January 30, 2026. The letter emphasizes the company's responsibili… | Read Filing EDGAR |
| Feb. 6, 2026 | CORRESP | Neutral/Informational | Moderate | Benitec Biopharma Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-3. The company aims for the registrati… | Read Filing EDGAR |
| Sep. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Benitec Biopharma Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3. They are seeking for it to become… | Read Filing EDGAR |
| Sep. 25, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated September 25, 2025, informs Jerel Banks, CEO of Benitec Biopharma Inc., that the SEC has not reviewed and will not review their registration statement… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.